OWCP (OWC Pharmaceutical Research) EPS (Basic): $-0.03 (TTM As of Sep. 2019)


What is OWC Pharmaceutical Research EPS (Basic)?

OWC Pharmaceutical Research OWCP -90.00% EPS (Basic) is $-0.03 as of Sep. 2019.

OWC Pharmaceutical Research's basic earnings per share (Basic EPS) for the three months ended in Sep. 2019 was $-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.03.

OWC Pharmaceutical Research's EPS (Diluted) for the three months ended in Sep. 2019 was $-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.07.

OWC Pharmaceutical Research's EPS without NRI for the three months ended in Sep. 2019 was $-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2019 was -0.08.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

OWC Pharmaceutical Research  (OTCPK:OWCP) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

OWC Pharmaceutical Research EPS (Basic) Related Terms

OWC Pharmaceutical Research EPS (Basic) Historical Data

* Premium members only.

The historical data trend for OWC Pharmaceutical Research's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research EPS (Basic) Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only -0.10 -0.02 -0.02 -0.03 -0.09

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.05 -0.01 0.04 -0.01

OWC Pharmaceutical Research EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

OWC Pharmaceutical Research's Basic EPS for the fiscal year that ended in Dec. 2018 is calculated as

Basic EPS (A: Dec. 2018 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-10.258-0.179)/148.066
=-0.07

OWC Pharmaceutical Research's Basic EPS for the quarter that ended in Sep. 2019 is calculated as

Basic EPS (Q: Sep. 2019 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.287-0.062)/232.581
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.03 mean?
OWC Pharmaceutical Research (OWCP) has a EPS (Basic) of $-0.03 as of Sep. 2019. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on OWC Pharmaceutical Research and its competitors.
Is OWC Pharmaceutical Research's EPS (Basic) too high?
OWC Pharmaceutical Research's current EPS (Basic) is $-0.03.
How does OWC Pharmaceutical Research's EPS (Basic) compare to PARNF and CANB?
OWC Pharmaceutical Research's EPS (Basic) of $-0.03 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on OWC Pharmaceutical Research and its competitors. OWC Pharmaceutical Research's current EPS (Basic) is $-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OWC Pharmaceutical Research stock overvalued right now?
OWC Pharmaceutical Research (OWCP) has a current EPS (Basic) of $-0.03. The current EPS (Basic) is $-0.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For OWC Pharmaceutical Research (OWCP), the current EPS (Basic) is $-0.03 as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OWC Pharmaceutical Research Business Description

Address 2 Ben Gurion Street, Ramat Gan, ISR, 4514760
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.